- Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)
-
Ko J, Moon SJ
- KMID: 2544735
- Diabetes Metab J.
- 2023 Jul;47(4):571-572.
- doi: 10.4093/dmj.2023.0164
-
- CITED
-
- Close
- SHARE
-
- Close
- The Beneficial Effect of Glycemic Control against Adverse Outcomes in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
-
Lee DH
- KMID: 2544727
- Diabetes Metab J.
- 2023 Jul;47(4):484-486.
- doi: 10.4093/dmj.2023.0165
-
- CITED
-
- Close
- SHARE
-
- Close
- Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)
-
Lin TY, Kang EYC, Shao SC, Lai ECC, Hwang YS
- KMID: 2544736
- Diabetes Metab J.
- 2023 Jul;47(4):573-574.
- doi: 10.4093/dmj.2023.0188
-
- CITED
-
- Close
- SHARE
-
- Close
- Regulation of Cellular Senescence in Type 2 Diabetes Mellitus: From Mechanisms to Clinical Applications
-
Iwasaki K, Abarca C, Aguayo-Mazzucato C
- KMID: 2544724
- Diabetes Metab J.
- 2023 Jul;47(4):441-453.
- doi: 10.4093/dmj.2022.0416
Cellular senescence is accelerated by hyperglycemia through multiple pathways. Therefore, senescence is an important cellular mechanism to consider in the pathophysiology of type 2 diabetes mellitus (T2DM) and an additional... -
- CITED
-
- Close
- SHARE
-
- Close
- Change Profiles and Functional Targets of MicroRNAs in Type 2 Diabetes Mellitus Patients with Obesity
-
Lu G, Gao H, Dong Z, Jiang S, Hu R, Wang C
- KMID: 2544734
- Diabetes Metab J.
- 2023 Jul;47(4):559-570.
- doi: 10.4093/dmj.2022.0226
Background: MicroRNAs (miRNAs) exert an essential contribution to obesity and type 2 diabetes mellitus (T2DM). This study aimed to investigate the differences of miRNAs in the presence and absence of... -
- CITED
-
- Close
- SHARE
-
- Close
- Rediscovering Primary Cilia in Pancreatic Islets
-
Lee EY, Hughes JW
- KMID: 2544725
- Diabetes Metab J.
- 2023 Jul;47(4):454-469.
- doi: 10.4093/dmj.2022.0442
Primary cilia are microtubule-based sensory and signaling organelles on the surfaces of most eukaryotic cells. Despite their early description by microscopy studies, islet cilia had not been examined in the... -
- CITED
-
- Close
- SHARE
-
- Close
- The Role of Echocardiography in Evaluating Cardiovascular Diseases in Patients with Diabetes Mellitus
-
Lee SH, Park JH
- KMID: 2544726
- Diabetes Metab J.
- 2023 Jul;47(4):470-483.
- doi: 10.4093/dmj.2023.0036
Patients with diabetes mellitus are highly susceptible to cardiovascular complications, which are directly correlated with cardiovascular morbidity and mortality. In addition to coronary artery disease, there is growing awareness of... -
- CITED
-
- Close
- SHARE
-
- Close
- Two-Year Changes in Diabetic Kidney Disease Phenotype and the Risk of Heart Failure: A Nationwide Population-Based Study in Korea
-
Lee SE, Yoo J, Choi HS, Han K, Kim KA
- KMID: 2544731
- Diabetes Metab J.
- 2023 Jul;47(4):523-534.
- doi: 10.4093/dmj.2022.0096
Background: Diabetic kidney disease (DKD) is a risk factor for hospitalization for heart failure (HHF). DKD could be classified into four phenotypes by estimated glomerular filtration rate (eGFR, normal vs.... -
- CITED
-
- Close
- SHARE
-
- Close
- Ultra-Processed Food Consumption and Obesity in Korean Adults
-
Shim JS, Ha KH, Kim DJ, Kim HC
- KMID: 2544733
- Diabetes Metab J.
- 2023 Jul;47(4):547-558.
- doi: 10.4093/dmj.2022.0026
Background: This study aimed to investigate the association between consumption of ultra-processed foods (UPF) and obesity in Korean adults. Methods: We included the Cardiovascular and Metabolic Diseases Etiology Research Center cohort... -
- CITED
-
- Close
- SHARE
-
- Close
- The Risk of Type 2 Diabetes Mellitus according to Changes in Obesity Status in Late Middle-Aged Adults: A Nationwide Cohort Study of Korea
-
Moon JH, Jang Y, Oh TJ, Jung SY
- KMID: 2544730
- Diabetes Metab J.
- 2023 Jul;47(4):514-522.
- doi: 10.4093/dmj.2022.0159
Background: Although obesity is a well-known risk factor of type 2 diabetes mellitus (T2DM), there is scant data on discriminating the contribution of previous obesity and recent weight gain on... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacologic Activation of Angiotensin-Converting Enzyme II Alleviates Diabetic Cardiomyopathy in db/db Mice by Reducing Reactive Oxidative Stress
-
Kim D, Jeong W, Kim Y, Lee J, Cho SW, Oh CM, Park R
- KMID: 2544728
- Diabetes Metab J.
- 2023 Jul;47(4):487-499.
- doi: 10.4093/dmj.2022.0125
Background: Diabetes mellitus is one of the most common chronic diseases worldwide, and cardiovascular disease is the leading cause of morbidity and mortality in diabetic patients. Diabetic cardiomyopathy (DCM) is... -
- CITED
-
- Close
- SHARE
-
- Close
- Beneficial Effects of a Curcumin Derivative and Transforming Growth Factor-β Receptor I Inhibitor Combination on Nonalcoholic Steatohepatitis
-
Ha KB, Lee ES, Park NW, Jo SH, Shim S, Kim DK, Ahn CM, Chung CH
- KMID: 2544729
- Diabetes Metab J.
- 2023 Jul;47(4):500-513.
- doi: 10.4093/dmj.2022.0110
Background: Curcumin 2005-8 (Cur5-8), a derivative of curcumin, improves fatty liver disease via AMP-activated protein kinase activation and autophagy regulation. EW-7197 (vactosertib) is a small molecule inhibitor of transforming growth... -
- CITED
-
- Close
- SHARE
-
- Close
- Glycemic Control and Adverse Clinical Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus: Results from KNOW-CKD
-
Heo GY, Koh HB, Kim HW, Park JT, Yoo TH, Kang SW, Kim J, Kim SW, Kim YH, Sung SA, Oh KH, Han SH
- KMID: 2544732
- Diabetes Metab J.
- 2023 Jul;47(4):535-546.
- doi: 10.4093/dmj.2022.0112
Background: The optimal level of glycosylated hemoglobin (HbA1c) to prevent adverse clinical outcomes is unknown in patients with chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM). Methods: We analyzed... -
- CITED
-
- Close
- SHARE
-
- Close
